Congenital Brain Tumors: Surgical Outcomes and Long-Term Prognostic Factors

Ahmet Ilkay Isikay1, Muhammet Enes Gurses1, Neslihan Nisa Gecici1

  • 1Department of Neurosurgery, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

World Neurosurgery
|September 12, 2024
PubMed

Insights

Surgical resection is vital for infant congenital brain tumors (CBTs). However, high-grade malignant tumors present poor prognosis despite aggressive treatment, highlighting the need for improved therapeutic strategies.

Area of Science:

  • Pediatric Neurosurgery
  • Oncology
  • Congenital Neuropathology

Background:

  • Congenital brain tumors (CBTs) are rare and pose significant challenges in infant management.
  • Long-term outcomes and prognostic factors for CBTs in infants are not well-defined.

Purpose of the Study:

  • To assess the long-term results of surgical intervention for CBTs in infants under one year of age.
  • To identify key factors influencing survival rates in this pediatric population.

Main Methods:

  • Retrospective analysis of 70 infants undergoing gross total or subtotal resection for CBTs (2001-2019).
  • Inclusion of demographic, clinical, and tumor characteristic data, including hydrocephalus and adjuvant therapies.
  • Cox regression analysis to determine survival predictors.

Main Results:

  • Overall 5- and 10-year survival rates were 78% and 63%, respectively.
  • High-grade tumors, preoperative hydrocephalus, larger tumor size, and ventriculoperitoneal shunt placement were linked to reduced survival.
  • Tumor grade and size independently predicted poor prognosis.

Conclusions:

  • Surgical resection is essential for infant CBTs, but malignant tumors have poor long-term outcomes.
  • Neurological sequelae are common in long-term survivors, emphasizing the need for comprehensive care.
Abstract